Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Gaurav Bidhuri, 2017 World Boxing Championship bronze medallist, joined hands with the Del
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
- FIFA : Over 100 female footballers urge FIFA to reconsider partnership with Saudi oil giant
- Ecuador ready to make history against Uruguay: Beccacece
Oxford Covid vaccine trials delayed over safety approvals Last Updated : 06 Sep 2020 11:38:59 PM IST File Photo The clinical trials for the Covid-19 vaccine candidate developed by the University of Oxford, which was expected to start at The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh, have been delayed by at least a week.
The trials that were expected to commence in the first week of September have been delayed due to the safety approval pending from the Data Safety and Monitoring Board (DSMB) for the first 100 candidates selected to undergo the trials, the institute told IANS.In result, the further recruitment of the candidates for the trials has been put on hold."For the time being, the further recruitment of the candidates for the trials for the Oxford vaccine is on hold because we are waiting for the approval for safety of the first 100 participants recruited till now from the Data Safety and Monitoring Board. In this light, we would be able to update you regarding any development on this front by next weekend only," said Prof. Dr. Madhu Gupta, the principal investigator of the vaccine trial scheduled at the PGIMER.The premier institute said it received 400 volunteers for the trials. Of them, 253 would be administered the first dose of the undertrial vaccine.Gupta had earlier informed that 16-member staff, including herself, would supervise the clinical trials.The PGIMER is among the 17 sites selected for the human clinical trials of the adenovirus-based Covid-19 vaccine candidate developed jointly by AstraZeneca and the University of Oxford. India.The institute will participate in the second and third phases of the proposed vaccine. The vaccine's production and marketing will be looked after by the Serum Institute of India (SII), one of the largest vaccine producers in the country.Adar Poonawalla, Chief Executive Officer of the Pune-based firm, had said the coronavirus vaccine might be ready by the end of this year.
IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
172.31.16.186